|
 |
| home > epc > winter 2003 > current legal issues regarding medicinal products in finland |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
Reimbursement for Medicinal Products
The latest ruling by the European Court of Justice (ECJ) makes the implementation of procedural changes to the Finnish reimbursement system for medicinal products imminent. The ECJ ruling is connected to the appeal filed to the Commission by Pharma Industry Finland in April 1997 based on the Finnish Government's flawed implementation of the so-called 'Transparency Directive' (89/105/EEC). The Commission brought Finland before the ECJ in June 2000.
In its judgement published on 12th June 2003, the ECJ ruled that Finland has failed to fulfil its obligations under the Transparency Directive. Finland has refused to implement the measures regulating the pricing of and reimbursement for medicinal products with regard to medicinal products that are subject to a higher rate of health insurance coverage.
Finland has a two-phased reimbursement system. In addition to the basic refund group, there are also two special refund categories that include medicinal product or generic medical products that are essential for the treatment of a serious or chronic illness and are eligible for refunds of 75 and 100 per cent. Measured by value of sales, over one-third of all medicines sold in Finland fall into the special refund categories.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Small Scale Biomanufacturing – clinical trials, cell & gene therapies
18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol
This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >> |
|
 |
News and Press Releases |
 |
Ultra slim and ultra quick
More info >>
|
|
 |
